2023 Q2 Form 10-Q Financial Statement
#000182912623003708 Filed on May 23, 2023
Income Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $390.0K | $926.2K | |
YoY Change | 187.72% | ||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $390.0K | $926.2K | |
YoY Change | 187.72% | ||
Operating Profit | -$393.9K | -$926.2K | |
YoY Change | 190.6% | ||
Interest Expense | $790.0K | $1.252M | |
YoY Change | 467.61% | ||
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $399.3K | $325.9K | $0.00 |
YoY Change | 10899.81% | ||
Income Tax | $160.4K | $254.6K | |
% Of Pretax Income | 40.17% | 78.1% | |
Net Earnings | $238.9K | $71.38K | |
YoY Change | -1281.54% | ||
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $0.03 | $0.00 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 7.304M shares | 14.72M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $500.0K | $391.6K | $151.0K |
YoY Change | 29.37% | 159.35% | |
Cash & Equivalents | $460.2K | $391.6K | $151.0K |
Short-Term Investments | |||
Other Short-Term Assets | $0.00 | $14.51K | |
YoY Change | -100.0% | ||
Inventory | |||
Prepaid Expenses | $11.21K | $14.51K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $471.4K | $406.1K | $151.0K |
YoY Change | -25.87% | 168.97% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $43.00M | $118.6M | |
YoY Change | -62.65% | ||
Other Assets | $149.6K | ||
YoY Change | |||
Total Long-Term Assets | $42.96M | $118.6M | $149.6K |
YoY Change | -62.69% | 79144.82% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $471.4K | $406.1K | $151.0K |
Total Long-Term Assets | $42.96M | $118.6M | $149.6K |
Total Assets | $43.43M | $119.0M | $300.6K |
YoY Change | -62.48% | 39475.61% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $1.207M | $1.034M | $37.37K |
YoY Change | 4456.38% | 2667.89% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $1.300M | $825.0K | $250.0K |
YoY Change | 230.0% | ||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $4.355M | $3.039M | $287.4K |
YoY Change | 4932.59% | 957.48% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $4.000M | $4.025M | |
YoY Change | -0.62% | ||
Total Long-Term Liabilities | $4.000M | $4.025M | $0.00 |
YoY Change | -0.62% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.355M | $3.039M | $287.4K |
Total Long-Term Liabilities | $4.000M | $4.025M | $0.00 |
Total Liabilities | $8.380M | $7.064M | $287.4K |
YoY Change | 103.82% | 2358.12% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$7.909M | -$6.658M | |
YoY Change | 127.54% | ||
Common Stock | $321.00 | $321.00 | $287.00 |
YoY Change | 0.0% | 11.85% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$7.909M | -$6.658M | $13.23K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $43.43M | $119.0M | $300.6K |
YoY Change | -62.48% | 39475.61% |
Cashflow Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $238.9K | $71.38K | |
YoY Change | -1281.54% | ||
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$500.0K | -$589.8K | |
YoY Change | 40.96% | ||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $76.38M | -$654.6K | |
YoY Change | -166.42% | ||
Cash From Investing Activities | $76.38M | -$654.6K | |
YoY Change | -166.42% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -75.82M | $1.400M | -45.01K |
YoY Change | -165.59% | -3210.64% | |
NET CHANGE | |||
Cash From Operating Activities | -500.0K | -$589.8K | |
Cash From Investing Activities | 76.38M | -$654.6K | |
Cash From Financing Activities | -75.82M | $1.400M | -45.01K |
Net Change In Cash | 60.00K | $155.7K | -45.01K |
YoY Change | -74.52% | -446.01% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$500.0K | -$589.8K | |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001907730 | |
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q1 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
usd | |
CY2022Q4 | YOTAU |
Deferred Credit Term Extension Fee Paid By Target Company
DeferredCreditTermExtensionFeePaidByTargetCompany
|
usd | |
CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
usd | |
CY2022Q1 | YOTAU |
Franchise Tax Expenses
FranchiseTaxExpenses
|
usd | |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
usd | |
CY2022Q1 | YOTAU |
Marketable Securitie Gain Loss
MarketableSecuritieGainLoss
|
usd | |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
usd | |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
usd | |
CY2022Q1 | YOTAU |
Basic And Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
|
shares | |
CY2022Q1 | YOTAU |
Basic And Diluted Net Income Per Share Common Stock Subject To Possible Redemption
BasicAndDilutedNetIncomePerShareCommonStockSubjectToPossibleRedemption
|
||
CY2022Q1 | YOTAU |
Basic And Diluted Net Loss Per Share Common Stock Attributable To Yotta Acquisition Corporation
BasicAndDilutedNetLossPerShareCommonStockAttributableToYottaAcquisitionCorporation
|
||
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
usd | |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
usd | |
CY2022Q1 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
usd | |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | |
CY2022Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
usd | |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
usd | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
usd | |
CY2022Q1 | YOTAU |
Cash Deposited In Trust Account
CashDepositedInTrustAccount
|
usd | |
CY2022Q1 | YOTAU |
Cash Withdrawn From Trust Account To Pay Taxe
CashWithdrawnFromTrustAccountToPayTaxe
|
usd | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2022Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2022Q1 | YOTAU |
Term Extension Fee Paid By Target Company
TermExtensionFeePaidByTargetCompany
|
usd | |
CY2023Q1 | YOTAU |
Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
|
usd | |
CY2022Q1 | YOTAU |
Remeasurement Of Common Stock To Redemptions Value
RemeasurementOfCommonStockToRedemptionsValue
|
usd | |
CY2023Q1 | YOTAU |
Deferred Offering Costs In Accrued Offering Expenses
DeferredOfferingCostsInAccruedOfferingExpenses
|
usd | |
CY2023Q1 | YOTAU |
Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
|
usd | |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
001-41357 | |
CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Yotta Acquisition Corporation | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
86-3374167 | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1185 Avenue of the Americas | |
CY2023Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 301 | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | |
CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10036 | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
(212) | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
612-1400 | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7303594 | shares |
CY2023Q1 | us-gaap |
Cash
Cash
|
391602 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
235864 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
14511 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
84486 | usd |
CY2022Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
10850 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
406113 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
331200 | usd |
CY2023Q1 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
118558173 | usd |
CY2022Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
116651461 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
118964286 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
116982661 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1034360 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
632531 | usd |
CY2023Q1 | YOTAU |
Franchise Tax Payable
FranchiseTaxPayable
|
39945 | usd |
CY2022Q4 | YOTAU |
Franchise Tax Payable
FranchiseTaxPayable
|
186180 | usd |
CY2023Q1 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
564484 | usd |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
309931 | usd |
CY2023Q1 | YOTAU |
Deferred Credit Term Extension Fee Paid By Target Company
DeferredCreditTermExtensionFeePaidByTargetCompany
|
575100 | usd |
CY2023Q1 | YOTAU |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
825000 | usd |
CY2022Q4 | YOTAU |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
-0 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3038889 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1128642 | usd |
CY2023Q1 | YOTAU |
Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
|
4025000 | usd |
CY2022Q4 | YOTAU |
Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
|
4025000 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
7063889 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
5153642 | usd |
CY2023Q1 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
11500000 | shares |
CY2022Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
11500000 | shares |
CY2023Q1 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.31 | |
CY2022Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.14 | |
CY2023Q1 | us-gaap |
Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
|
118558173 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
|
116651461 | usd |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3218499 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3218499 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3218499 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3218499 | shares |
CY2023Q1 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
11500000 | shares |
CY2022Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
11500000 | shares |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
321 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
321 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6658097 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-4822763 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6657776 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4822442 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
118964286 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
116982661 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
886227 | usd |
CY2023Q1 | YOTAU |
Franchise Tax Expenses
FranchiseTaxExpenses
|
39945 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-926172 | usd |
CY2023Q1 | YOTAU |
Marketable Securitie Gain Loss
MarketableSecuritieGainLoss
|
1252103 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
325931 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
254553 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
71378 | usd |
CY2023Q1 | YOTAU |
Basic And Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
|
11500000 | shares |
CY2023Q1 | YOTAU |
Basic And Diluted Net Income Per Share Common Stock Subject To Possible Redemption
BasicAndDilutedNetIncomePerShareCommonStockSubjectToPossibleRedemption
|
0.00 | |
CY2023Q1 | YOTAU |
Basic And Diluted Weighted Average Shares Outstanding Common Stock Attributable To Yotta Acquisition Corporation
BasicAndDilutedWeightedAverageSharesOutstandingCommonStockAttributableToYottaAcquisitionCorporation
|
3218499 | shares |
CY2022Q1 | YOTAU |
Basic And Diluted Weighted Average Shares Outstanding Common Stock Attributable To Yotta Acquisition Corporation
BasicAndDilutedWeightedAverageSharesOutstandingCommonStockAttributableToYottaAcquisitionCorporation
|
2499999 | shares |
CY2023Q1 | YOTAU |
Basic And Diluted Net Loss Per Share Common Stock Attributable To Yotta Acquisition Corporation
BasicAndDilutedNetLossPerShareCommonStockAttributableToYottaAcquisitionCorporation
|
0.00 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4822442 | usd |
CY2023Q1 | YOTAU |
Remeasurement Of Common Stock To Redemption Value
RemeasurementOfCommonStockToRedemptionValue
|
-1906712 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
71378 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6657776 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13231 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13231 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-71378 | usd |
CY2023Q1 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
1252103 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-69975 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-10850 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
401829 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
254553 | usd |
CY2023Q1 | YOTAU |
Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
|
-146235 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-589753 | usd |
CY2023Q1 | YOTAU |
Cash Deposited In Trust Account
CashDepositedInTrustAccount
|
1150100 | usd |
CY2023Q1 | YOTAU |
Cash Withdrawn From Trust Account To Pay Taxe
CashWithdrawnFromTrustAccountToPayTaxe
|
495491 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-654609 | usd |
CY2023Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
825000 | usd |
CY2023Q1 | YOTAU |
Term Extension Fee Paid By Target Company
TermExtensionFeePaidByTargetCompany
|
575100 | usd |
CY2022Q1 | YOTAU |
Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
|
45009 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1400100 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-45009 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
155738 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-45009 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
235864 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
196000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
391602 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
150991 | usd |
CY2023Q1 | YOTAU |
Remeasurement Of Common Stock To Redemptions Value
RemeasurementOfCommonStockToRedemptionsValue
|
1906712 | usd |
CY2022Q1 | YOTAU |
Deferred Offering Costs In Accrued Offering Expenses
DeferredOfferingCostsInAccruedOfferingExpenses
|
22100 | usd |
CY2022Q1 | YOTAU |
Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
|
3500 | usd |
CY2023Q1 | YOTAU |
Transaction Costs
TransactionCosts
|
6764402 | usd |
CY2023Q1 | YOTAU |
Underwriting Fees
UnderwritingFees
|
2300000 | usd |
CY2023Q1 | YOTAU |
Deferred Underwriting Fees
DeferredUnderwritingFees
|
4025000 | usd |
CY2023Q1 | YOTAU |
Other Offering Costs
OtherOfferingCosts
|
439402 | usd |
CY2022Q2 | YOTAU |
Proceeds From Ipo And Private Placement
ProceedsFromIpoAndPrivatePlacement
|
115000000 | usd |
CY2023Q1 | YOTAU |
Percentage Of Asset Held In Trust Account
PercentageOfAssetHeldInTrustAccount
|
0.80 | pure |
CY2023Q1 | YOTAU |
Business Combination Percentage Of Voting Securities
BusinessCombinationPercentageOfVotingSecurities
|
0.50 | pure |
CY2023Q1 | YOTAU |
Net Tangible Assets
NetTangibleAssets
|
5000001 | usd |
CY2023Q1 | us-gaap |
Deposits
Deposits
|
120000 | usd |
CY2023Q1 | YOTAU |
Issued Shares Description
IssuedSharesDescription
|
the Company will issue 17.5 million shares of common stock to the former security holders of the Target. In addition, the stockholders of the Target are entitled to receive an additional 5.0 million shares of common stock (current valuation of $50.0 million) based on achieving certain revenue targets for 2024 and 5 million shares of common stock (current valuation of $50 million) based on achieving certain revenue targets for 2025. In the event the Company or the Target validly terminates the Agreement because of a default by the other, a breakup fee of $3.0 million will be due to the terminating party. | |
CY2023Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
575000 | usd |
CY2023Q1 | us-gaap |
Deposits
Deposits
|
1150000 | usd |
CY2023Q1 | YOTAU |
Aggregate Principal Amount
AggregatePrincipalAmount
|
250000 | usd |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
391602 | usd |
CY2023Q1 | YOTAU |
Working Capital Deficit
WorkingCapitalDeficit
|
2028347 | usd |
CY2023Q1 | us-gaap |
Deposits
Deposits
|
1150000 | usd |
CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_844_eus-gaap--UseOfEstimates_z4AuEsAh0oS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zla9XCk0Ihk">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these unaudited condensed financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q1 | us-gaap |
Cash
Cash
|
391602 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
235864 | usd |
CY2023Q1 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
16666 | shares |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
|
123900 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
7.38 | |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.7810 | pure |
CY2022Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | pure |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.21 | pure |
CY2022Q1 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.21 | pure |
CY2023Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2023Q1 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
CY2022Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
CY2023Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zhT7hatFTaM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_z5bIUo9Mo0Ke">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_c20230331_pp0p0" title="Federal Depository Insurance coverage">250,000</span>. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q1 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
11843500 | shares |
CY2022Q2 | YOTAU |
Proceeds From Ipo And Private Placement
ProceedsFromIpoAndPrivatePlacement
|
115000000 | usd |
CY2022 | YOTAU |
Gross Proceeds From Initial Public Offering
GrossProceedsFromInitialPublicOffering
|
115000000 | usd |
CY2022 | YOTAU |
Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
|
-690000 | usd |
CY2022 | YOTAU |
Proceeds Allocated To Public Rights
ProceedsAllocatedToPublicRights
|
-8280000 | usd |
CY2022 | YOTAU |
Offering Costs Of Public Shares
OfferingCostsOfPublicShares
|
-6236777 | usd |
CY2022 | YOTAU |
Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
|
16858238 | usd |
CY2022 | YOTAU |
Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
|
116651461 | usd |
CY2023Q1 | YOTAU |
Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
|
1906712 | usd |
CY2023Q1 | YOTAU |
Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
|
118558173 | usd |
CY2023Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
575000 | usd |
CY2023Q1 | YOTAU |
Expenses Related To Business Combination
ExpensesRelatedToBusinessCombination
|
250000 | usd |
CY2023Q1 | YOTAU |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
825000 | usd |
CY2022Q4 | YOTAU |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
0 | usd |
CY2023Q1 | YOTAU |
Working Capital Loans
WorkingCapitalLoans
|
0 | usd |
CY2022 | YOTAU |
Working Capital Loans
WorkingCapitalLoans
|
0 | usd |
CY2022Q2 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
10000 | usd |
CY2023Q1 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
30000 | usd |
CY2022Q1 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
0 | usd |
CY2023Q1 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
30000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
80000 | usd |
CY2023Q1 | YOTAU |
Initial Public Offering Filings Fee
InitialPublicOfferingFilingsFee
|
1000 | usd |
CY2022Q1 | YOTAU |
Initial Public Offering Filings Fee
InitialPublicOfferingFilingsFee
|
0 | usd |
CY2023Q1 | YOTAU |
Periodic Compliance Filings Fee
PeriodicComplianceFilingsFee
|
1000 | usd |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3218499 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3218499 | shares |